HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MICOT PHARMA-B

24.100

-1.940-7.45%

Volume:725.60K

Turnover:18.34M

Market Cap:7.99B

PE:- -

High:26.500

Open:26.060

Low:23.840

Close:26.040

52wk High:45.040

52wk Low:23.840

Shares:331.74M

HK Float Shares:280.07M

Volume Ratio:1.09

T/O Rate:0.26%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:-33.17%

PB:7.24

PE(LYR):- -

PS:23358.91

Loading ...

Overview Company News Filings

UISEE Technologies Joins Southbound Stock Connect List

MT Newswires Live

Shaanxi Micot H Shares Join Shanghai and Shenzhen Stock Connect Eligible List

Micot Pharma Posts Wider H1 Loss but Turns to Positive Operating Cash Flow After Licensing Deal and IPO Windfall

Bulletin Express

Shaanxi Micot Pharmaceutical Technology Co - Loss for Period Rmb231.7 Mln for Six Months Ended June 30, 2026

THOMSON REUTERS

Shaanxi Micot Pharmaceutical Technology - Determined That no Interim Dividend Will be Paid

THOMSON REUTERS

Shaanxi Micot Interim Net Loss Widens 364.3% to RMB 231.7 Million in FY26 H1

Micot Pharma Concludes Phase 2 Trial of AIS Drug

MT Newswires Live

MICOT Pharma's Stroke Drug Completes Mid-Stage Trial in China

Shaanxi Micot Says Phase II Trial of Mt200605 Meets Primary Endpoint in Acute Ischemic Stroke in China

MICOT PHARMA-B (02335) Selected for Hang Seng Composite Index Inclusion

Shaanxi Micot Pharmaceutical Joins Hang Seng Composite Index from Sept. 7

Shaanxi Micot Pharmaceutical Technology Co - to be Included in Hang Seng Composite Index Effective 7 September 2026

THOMSON REUTERS

Hong Kong Stock Market Flash | Micot Pharma-B (02335) Surges Nearly 6% in Afternoon Session as Innovative Drug XTL6001 Makes Third Appearance on International Academic Stage

Shaanxi Micot Pharma to Present Results of XTL6001 at International Conferences

MT Newswires Live

Shaanxi Micot Says Xtl6001 Study Accepted for Oral Presentation at EASD 2026

Micot Pharma Sets 28 August 2026 Board Meeting to Review H1 2026 Results and Potential Interim Dividend

Bulletin Express

Shaanxi Micot Pharma Schedules Board Meeting to Review Interim Results

MICOT PHARMA-B (02335) Surges 3% After MT200605 Data Accepted for Oral Presentation at 2026 World Stroke Conference

Micot Pharma’s MT200605 Data Selected for Oral Presentation at 2026 World Stroke Congress, Phase II Hits Primary Endpoint

Bulletin Express

Shaanxi Micot Says Mt200605 Phase I, Preclinical Data Accepted for Oral Presentation at World Stroke Congress 2026

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/02335/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02335","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02335\",,,,,undefined,":{"symbol":"02335","market":"HK","secType":"STK","nameCN":"MICOT PHARMA-B","latestPrice":24.1,"timestamp":1789027722148,"preClose":26.04,"halted":0,"volume":725600,"delay":0,"changeRate":-0.07450076804915506,"floatShares":280071100,"shares":331740350,"eps":0,"marketStatus":"Closed","change":-1.94,"latestTime":"09-10 16:08:42","open":26.06,"high":26.5,"low":23.84,"amount":18336948,"amplitude":0.102151,"askPrice":24.9,"askSize":400,"bidPrice":24.1,"bidSize":11000,"shortable":0,"etf":0,"ttmEps":-1.265,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":5,"adr":0,"listingDate":1782230400000,"exchange":"SEHK","adjPreClose":26.04,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"volumeRatio":1.09212,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02335\",,,,,undefined,":{"symbol":"02335","floatShares":280071100,"roa":"-33.17%","roe":"--","lyrEps":0,"volumeRatio":1.09212,"shares":331740350,"dividePrice":0,"high":26.5,"amplitude":0.102151,"preClose":26.04,"low":23.84,"week52Low":23.84,"pbRate":"7.24","psRate":"23358.91","week52High":45.04,"institutionHeld":0,"latestPrice":24.1,"committee":0.929825,"eps":0,"divideRate":0,"volume":725600,"delay":0,"ttmEps":-1.265,"open":26.06,"prevYearClose":18.2,"prevWeekClose":28.56,"prevMonthClose":28.5,"prevQuarterClose":36.54,"fiveDayClose":28.54,"twentyDayClose":30.1,"sixtyDayClose":18.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02335\",params:#limit:5,,,undefined,":[{"date":"2026-08-28","symbol":"02335","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787880600000,"name":null,"time":"","dateTimestamp":1787846400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02335\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02335\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02335\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02335","date":"2026-09-09","current":-19.051383,"percent":1,"low":-69.768231,"twenty":-61.009443,"median":-47.355727,"eighty":-44.183357,"high":-20.283357,"avg":-48.189554,"sd":13.72329,"marketCap":8638518714},"quantilePoints":[{"date":"2026-06-26","current":-62.263046,"twenty":-62.206329,"median":-60.152258,"eighty":-47.220229,"marketCap":13110378632},{"date":"2026-07-03","current":-59.036408,"twenty":-61.58898,"median":-58.586203,"eighty":-56.979685,"marketCap":12440263125},{"date":"2026-07-10","current":-67.90436,"twenty":-64.475349,"median":-60.719674,"eighty":-57.773147,"marketCap":14291374278},{"date":"2026-07-17","current":-63.579874,"twenty":-66.545041,"median":-62.752488,"eighty":-58.496163,"marketCap":13428849368},{"date":"2026-07-24","current":-53.390071,"twenty":-65.175311,"median":-60.719674,"eighty":-54.684103,"marketCap":11279171900},{"date":"2026-07-31","current":-45.013396,"twenty":-64.653423,"median":-59.036408,"eighty":-53.47914,"marketCap":9527582852},{"date":"2026-08-07","current":-44.926163,"twenty":-63.868877,"median":-57.071612,"eighty":-46.373695,"marketCap":9527582852},{"date":"2026-08-14","current":-46.337925,"twenty":-63.512285,"median":-53.986784,"eighty":-46.072055,"marketCap":9839418781},{"date":"2026-08-21","current":-45.768087,"twenty":-63.046152,"median":-53.612744,"eighty":-46.072055,"marketCap":9739896676},{"date":"2026-08-28","current":-44.884949,"twenty":-62.24414,"median":-48.311254,"eighty":-45.062515,"marketCap":9554122080},{"date":"2026-09-04","current":-22.281867,"twenty":-61.878748,"median":-47.732514,"eighty":-44.372782,"marketCap":9474504396},{"date":"2026-09-09","current":-20.283357,"twenty":-61.009443,"median":-47.355727,"eighty":-44.183357,"marketCap":8638518714}],"updateTime":1789042030601},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02335\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665341192","title":"UISEE Technologies Joins Southbound Stock Connect List","url":"https://stock-news.laohu8.com/highlight/detail?id=2665341192","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665341192?lang=en_us&edition=fundamental","pubTime":"2026-09-08 11:42","pubTimestamp":1788838950,"startTime":"0","endTime":"0","summary":"Shares of UISEE Technologies  have been added to the list of eligible securities under the Shanghai- and Shenzhen-Hong Kong Stock Connect programs, effective Monday, according to a Tuesday bourse filing, giving Chinese investors cross-border trading access.The autonomous driving solutions company said the inclusion will attract long-term institutional investors and improve its trading liquidity.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XPP","02822","KBA","01511","KCAI","FLHK","BK1161","YANG","82843","02843","KWEB","YXI","02335","BK1171","ASHR","ASHS","02823","82823","YINN","FXP","FLCH","82822","CHAU","CWEB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665312590","title":"Shaanxi Micot H Shares Join Shanghai and Shenzhen Stock Connect Eligible List","url":"https://stock-news.laohu8.com/highlight/detail?id=2665312590","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665312590?lang=en_us&edition=fundamental","pubTime":"2026-09-07 21:51","pubTimestamp":1788789103,"startTime":"0","endTime":"0","summary":"Shaanxi Micot H shares join Shanghai and Shenzhen Stock Connect eligible listShaanxi Micot’s H shares were added to the eligible stocks list under Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Ko","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nNDLbxR8Zn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02335","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132304912","title":"Micot Pharma Posts Wider H1 Loss but Turns to Positive Operating Cash Flow After Licensing Deal and IPO Windfall","url":"https://stock-news.laohu8.com/highlight/detail?id=1132304912","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132304912?lang=en_us&edition=fundamental","pubTime":"2026-08-28 12:21","pubTimestamp":1787890904,"startTime":"0","endTime":"0","summary":"Micot Pharma released its unaudited results for the six months ended 30 June 2026, reporting a deeper interim loss as heavy R&D spending accelerated, yet generating positive operating cash flow and...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Micot Pharma Posts Wider H1 Loss but Turns to Positive Operating Cash Flow After Licensing Deal and IPO Windfall","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02335"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662055645","title":"Shaanxi Micot Pharmaceutical Technology Co - Loss for Period Rmb231.7 Mln for Six Months Ended June 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2662055645","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662055645?lang=en_us&edition=fundamental","pubTime":"2026-08-28 12:17","pubTimestamp":1787890650,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nFWN44O1NR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02335","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662055641","title":"Shaanxi Micot Pharmaceutical Technology - Determined That no Interim Dividend Will be Paid","url":"https://stock-news.laohu8.com/highlight/detail?id=2662055641","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662055641?lang=en_us&edition=fundamental","pubTime":"2026-08-28 12:17","pubTimestamp":1787890650,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nFWN44O1NR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02335","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662055612","title":"Shaanxi Micot Interim Net Loss Widens 364.3% to RMB 231.7 Million in FY26 H1","url":"https://stock-news.laohu8.com/highlight/detail?id=2662055612","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662055612?lang=en_us&edition=fundamental","pubTime":"2026-08-28 12:16","pubTimestamp":1787890585,"startTime":"0","endTime":"0","summary":"Shaanxi Micot interim net loss widens 364.3% to RMB 231.7 million in FY26 H1Shaanxi Micot Pharmaceutical posted an interim IFRS net loss of RMB 231.68 million, widening 364.3% year over year.R&D spend","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL9L0mYy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02335","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662776881","title":"Micot Pharma Concludes Phase 2 Trial of AIS Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2662776881","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662776881?lang=en_us&edition=fundamental","pubTime":"2026-08-27 15:04","pubTimestamp":1787814241,"startTime":"0","endTime":"0","summary":"Shaanxi Micot Pharmaceutical Technology  concluded the phase II clinical trial of MT200605 for the treatment of AIS, according to a Wednesday Hong Kong bourse filing.Shares of the Chinese biotechnology company were up nearly 2% in Thursday afternoon trading.The trial demonstrated significant and robust efficacy advantages with a favorable safety profile.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","02335"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114989011","title":"MICOT Pharma's Stroke Drug Completes Mid-Stage Trial in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1114989011","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114989011?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:42","pubTimestamp":1787755330,"startTime":"0","endTime":"0","summary":"MICOT PHARMA-B (02335) has announced the completion of a Phase II clinical trial for its self-developed candidate drug MT200605, designed to treat acute ischemic stroke (AIS).The trial demonstrated...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","IBBJ","02335","PSYK","MDTX","BMED","AIS","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662710265","title":"Shaanxi Micot Says Phase II Trial of Mt200605 Meets Primary Endpoint in Acute Ischemic Stroke in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2662710265","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662710265?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:39","pubTimestamp":1787755163,"startTime":"0","endTime":"0","summary":"Shaanxi Micot says Phase II trial of MT200605 meets primary endpoint in acute ischemic stroke in ChinaShaanxi Micot Pharmaceutical Technology reported completion of a Phase II China trial of MT200605 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL73JHbJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02335","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122580555","title":"MICOT PHARMA-B (02335) Selected for Hang Seng Composite Index Inclusion","url":"https://stock-news.laohu8.com/highlight/detail?id=1122580555","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122580555?lang=en_us&edition=fundamental","pubTime":"2026-08-24 12:14","pubTimestamp":1787544854,"startTime":"0","endTime":"0","summary":"MICOT PHARMA-B (02335) has announced its selection for inclusion as a constituent stock of the Hang Seng Composite Index, following the quarterly index review results released by Hang Seng Indexes...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSCI","02335","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661240119","title":"Shaanxi Micot Pharmaceutical Joins Hang Seng Composite Index from Sept. 7","url":"https://stock-news.laohu8.com/highlight/detail?id=2661240119","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661240119?lang=en_us&edition=fundamental","pubTime":"2026-08-24 12:05","pubTimestamp":1787544333,"startTime":"0","endTime":"0","summary":"Shaanxi Micot Pharmaceutical joins Hang Seng Composite Index from Sept. 7Shaanxi Micot Pharmaceutical Technology will be added to the Hang Seng Composite Index effective Sept. 7, 2026.Selection follow","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL1CffWY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02335","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661240186","title":"Shaanxi Micot Pharmaceutical Technology Co - to be Included in Hang Seng Composite Index Effective 7 September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2661240186","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661240186?lang=en_us&edition=fundamental","pubTime":"2026-08-24 12:04","pubTimestamp":1787544284,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44J09M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02335","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176624055","title":"Hong Kong Stock Market Flash | Micot Pharma-B (02335) Surges Nearly 6% in Afternoon Session as Innovative Drug XTL6001 Makes Third Appearance on International Academic Stage","url":"https://stock-news.laohu8.com/highlight/detail?id=1176624055","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176624055?lang=en_us&edition=fundamental","pubTime":"2026-08-18 13:50","pubTimestamp":1787032215,"startTime":"0","endTime":"0","summary":"MICOT PHARMA-B (02335) jumped nearly 6% in the afternoon session, trading up 5.94% at HK$32.12 with turnover reaching HK$12.68 million at the time of writing.On the news front, the company's...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","VXUS","BK1161","BK4585","159992","KCAI","IBBQ","BK4588","BK1574","02335","06978","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660482480","title":"Shaanxi Micot Pharma to Present Results of XTL6001 at International Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2660482480","media":"MT Newswires Live","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660482480?lang=en_us&edition=fundamental","pubTime":"2026-08-17 19:56","pubTimestamp":1786967799,"startTime":"0","endTime":"0","summary":"Shaanxi Micot Pharmaceutical Technology's (HKG:2335) research results for XTL6001 have been accepted for presentation at multiple academic conferences in the fields of diabetes, metabolic diseases, an","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02335","ASN.AU","BK1161","BK7095","BK7504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660548117","title":"Shaanxi Micot Says Xtl6001 Study Accepted for Oral Presentation at EASD 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2660548117","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660548117?lang=en_us&edition=fundamental","pubTime":"2026-08-17 18:37","pubTimestamp":1786963036,"startTime":"0","endTime":"0","summary":"Shaanxi Micot says XTL6001 study accepted for oral presentation at EASD 2026Shaanxi Micot Pharmaceutical Technology reported XTL6001 research accepted for EASD 2026 oral sessions, signaling rising ext","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL2bqbLW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02335","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191660124","title":"Micot Pharma Sets 28 August 2026 Board Meeting to Review H1 2026 Results and Potential Interim Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=1191660124","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191660124?lang=en_us&edition=fundamental","pubTime":"2026-08-14 22:06","pubTimestamp":1786716393,"startTime":"0","endTime":"0","summary":"Shaanxi Micot Pharmaceutical Technology Co., Ltd. (Micot Pharma) announced that its board of directors will convene on 28 August 2026 in Xi’an, Shaanxi, to review the unaudited interim results for...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02335"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659142638","title":"Shaanxi Micot Pharma Schedules Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659142638","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659142638?lang=en_us&edition=fundamental","pubTime":"2026-08-14 21:44","pubTimestamp":1786715089,"startTime":"0","endTime":"0","summary":"Shaanxi Micot Pharma schedules board meeting to review interim resultsShaanxi Micot Pharmaceutical Technology will hold a board meeting on Aug. 28, 2026.Agenda includes unaudited interim results for t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL8Bvl46:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02335","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169699749","title":"MICOT PHARMA-B (02335) Surges 3% After MT200605 Data Accepted for Oral Presentation at 2026 World Stroke Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=1169699749","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169699749?lang=en_us&edition=fundamental","pubTime":"2026-08-11 11:46","pubTimestamp":1786419979,"startTime":"0","endTime":"0","summary":"MICOT PHARMA-B (02335) rose more than 3%, trading at HK$29.94 as of the time of reporting, up 3.17%, with a turnover of HK$6.303 million. On August 10, the company announced that preclinical and...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0757428866.USD","KCAI","BK1161","BK4129","VXUS","02335","BK4588","BK4585","LU1815336091.USD","LU1878469433.USD","WSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103721845","title":"Micot Pharma’s MT200605 Data Selected for Oral Presentation at 2026 World Stroke Congress, Phase II Hits Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=1103721845","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103721845?lang=en_us&edition=fundamental","pubTime":"2026-08-10 23:46","pubTimestamp":1786376780,"startTime":"0","endTime":"0","summary":"Shaanxi Micot Pharmaceutical Technology Co., Ltd. (Micot Pharma) reported that pre-clinical and Phase I clinical results for its injectable neuroprotective candidate MT200605 have been accepted for...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02335"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658493738","title":"Shaanxi Micot Says Mt200605 Phase I, Preclinical Data Accepted for Oral Presentation at World Stroke Congress 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2658493738","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658493738?lang=en_us&edition=fundamental","pubTime":"2026-08-10 22:49","pubTimestamp":1786373366,"startTime":"0","endTime":"0","summary":"Shaanxi Micot says MT200605 Phase I, preclinical data accepted for oral presentation at World Stroke Congress 2026Shaanxi Micot Pharmaceutical Technology reported MT200605 preclinical and Phase I data","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL9Fb8Sf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02335"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":58,"code":"91000000","status":"200"}]}}